Pancreas Cancer: Clinical Trials

332 trials for Pancreas Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

95 completed, 85 recruiting, 59 unknown, 29 terminated. 86 Phase 1, 83 Not applicable, 79 Phase 2, 13 Phase 3, 7 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 186Completed 24, Recruiting 23, Terminated 12, Withdrawn 10, Active not recruiting 8, Unknown 7, Not yet recruiting 2
Not applicable83Completed 22, Unknown 20, Recruiting 19, Active not recruiting 8, Not yet recruiting 5, Withdrawn 4, Terminated 3, Enrolling by invitation 2
Phase 279Completed 19, Recruiting 19, Terminated 15, Active not recruiting 9, Withdrawn 8, Unknown 6, Not yet recruiting 3
Phase 313Recruiting 7, Completed 4, Terminated 1, Unknown 1
Early Phase 17Active not recruiting 2, Withdrawn 2, Completed 1, Not yet recruiting 1, Unknown 1
Phase 42Recruiting 1, Unknown 1

Follow Pancreas Cancer: new trials by email Literature Review of Pancreas Cancer trials Research Report on Pancreas Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC
certepetide, nab-paclitaxel, gemcitabine - Pancreas Cancer, Pancreatic Carcinoma
Phase 1 / Phase 2WithdrawnLisata Therapeutics, Inc.2030-01-012025-06-06
TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE)
Music-assisted relaxation and imagery (MARI) - Surgery, Stomach Cancer
Not applicableNot yet recruitingCase Comprehensive Cancer Center202027-01-012026-08-05
INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
INSPIRE (INtegrating Systematic PatIent-Reported Evaluations), Capture of patient-reported outcomes, Enhanced Clinician Awareness - Breast Cancer, Corpus Uteri Cancer
Not applicableRecruitingUniversity of Alabama at Birmingham27482026-10-022026-10-07
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Proton Transfer Reaction Mass Spectrometry Analysis - Pancreas Cancer, Hepatocellular Carcinoma
Not yet recruitingUniversity of Oklahoma20002026-10-012026-07-29
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
Actigraphy, Online Mindfulness Meditation, Smartphone Application-based Intervention - Hepatocellular Carcinoma, Pancreas Cancer
Not applicableNot yet recruitingCity of Hope Medical Center702026-10-012026-08-20
A Decision Support Tool for Pancreatic Cancer Screening -Aim 2
Electronic Decision Support Tool - Pancreas Cancer
Not applicableNot yet recruitingUNC Lineberger Comprehensive Cancer Center402026-09-082026-09-09
SURGIMEDIA: Utilization of Multimedia for Enhanced Surgical Consent
Standard Informed Consent, Multimedia Video - Based Informed Consent - Pancreas Cancer
Not applicableNot yet recruitingUNC Lineberger Comprehensive Cancer Center602026-09-012026-08-26
MT-601 Administered To Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
MT-601 dose 200 million cells, MT-601 dose 400 million cells, MT-601 dose 800 million cells - Pancreas Cancer, Pancreatic Cancer Metastatic
Phase 1Not yet recruitingMarker Therapeutics, Inc.382026-07-162026-05-13
Statewide Unified Network for Remote Intervention of Strength and Exercise
Exercise, Stretching - Gastric Cancer (Diagnosis), Esophagus Cancer
Not applicableNot yet recruitingAdventHealth Translational Research Institute1202026-07-012026-05-19
A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
PANXEON - Familial Pancreatic Cancer, Familial Pancreatic Carcinoma
RecruitingUniversità Vita-Salute San Raffaele6002026-06-032026-07-14
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
MRI, Endoscopic ultrasound - Pancreatic Cancer, Pancreas Cancer
RecruitingMemorial Sloan Kettering Cancer Center792026-05-202026-07-09
Impact of Consumption of Ultra-processed Foods in Individuals at High Risk of Cancer
educational workshop on nutrition + additional intervention on UPF tool and how to use it - Breast Cancer, Pancreas Cancer
Not applicableRecruitingGustave Roussy, Cancer Campus, Grand Paris1702026-05-042026-05-08
Axelopran for Advanced Cancer in Patients Receiving Opioids
axelopran - Breast Cancer, Lung Cancer
Phase 2RecruitingHealthPartners Institute342026-04-272026-05-05
Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma
Stereotactic body radiotherapy, Defactinib, Avutometinib - Pancreatic Adenocarcinoma, Cancer of the Pancreas
Phase 2RecruitingWashington University School of Medicine362026-04-102026-04-15
Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma
Blood sample - Pancreas Cancer
RecruitingInstitut Bergonié502026-03-272026-04-20
Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate
Pancreatic parenchymal injection of N-butyl-2- cyanoacrylate(Histoacryl®)Injection Group., Standard Pancreaticojejunostomy - Pancreaticoduodenectomy, Postoperative Pancreatic Fistula
Phase 2RecruitingMinia University902025-12-012025-12-02
Early Phase Study of KESONOTIDE™in Participants With Solid Tumours
A novel hGIIA-Vimentin Inhibitor, Dose expansion - Prostate Cancers, Breast Cancer
Phase 1 / Phase 2RecruitingFilamon LTD802025-11-072026-03-17
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
CEA-targeted CAR-T cells - Lung Cancer, Gastric Cancer
Phase 1RecruitingChongqing Precision Biotech Co., Ltd1082025-09-122025-10-02
Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)
Pancreatic parenchymal injection of N-butyl-2-cyanoacrylate(Histoacryl®) - Pancreaticoduodenectomy, Postoperative Pancreatic Fistula
Phase 1RecruitingMinia University302025-08-252026-09-11
A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC
AK154, Cadonilimab, Ivonescimab (SMT112 or AK112) Injection - Pancreas Cancer, Pancreas Cancer, Duct Cell Adenocarcinoma
Phase 1Not yet recruitingAkeso602025-07-222025-04-06

Showing 20 of 332. Sign in to see all of them.

Narrower conditions

Pancreatic Neoplasms (332)  ·  Stomach Neoplasms (41)  ·  Breast Neoplasms (40)  ·  Colorectal Neoplasms (39)  ·  Lung Neoplasms (33)  ·  Neoplasms (30)  ·  Colonic Neoplasms (29)  ·  Ovarian Neoplasms (29)  ·  Esophageal Neoplasms (28)  ·  Prostatic Neoplasms (18)  ·  Liver Neoplasms (17)  ·  Carcinoma, Non-Small-Cell Lung (16)  ·  Head and Neck Neoplasms (16)  ·  Neoplasm Metastasis (16)  ·  Bile Duct Neoplasms (15)

Broader conditions

Digestive System Diseases (332)  ·  Digestive System Neoplasms (332)  ·  Endocrine System Diseases (332)  ·  Neoplasms by Site (332)  ·  Endocrine Gland Neoplasms (331)  ·  Pancreatic Diseases (326)  ·  Neoplasms (302)  ·  Gastrointestinal Diseases (90)  ·  Gastrointestinal Neoplasms (81)  ·  Intestinal Diseases (73)  ·  Intestinal Neoplasms (72)  ·  Neoplasms by Histologic Type (69)  ·  Colonic Diseases (68)  ·  Pathological Conditions, Signs and Symptoms (62)  ·  Lung Diseases (56)

Interventions

Gemcitabine (25)  ·  Albumin-Bound Paclitaxel (10)  ·  130-nm albumin-bound paclitaxel (9)  ·  Fluorouracil (9)  ·  Oxaliplatin (9)  ·  Blood Specimen Collection (7)  ·  Irinotecan (7)  ·  pembrolizumab (7)  ·  Capecitabine (6)  ·  Taxes (6)  ·  folfirinox (6)  ·  Ascorbic Acid (5)  ·  Radiosurgery (5)  ·  Leucovorin (4)  ·  Magnetic Resonance Spectroscopy (4)

Sponsors

Washington University School of Medicine (16)  ·  Chongqing Precision Biotech Co., Ltd (5)  ·  Minia University (5)  ·  Cedars-Sinai Medical Center (4)  ·  Memorial Sloan Kettering Cancer Center (4)  ·  Second Affiliated Hospital of Guangzhou Medical University (4)  ·  UNC Lineberger Comprehensive Cancer Center (4)  ·  A2 Biotherapeutics Inc. (3)  ·  Abramson Cancer Center at Penn Medicine (3)  ·  Assiut University (3)  ·  Case Comprehensive Cancer Center (3)  ·  Catholic University of the Sacred Heart (3)  ·  Georgetown University (3)  ·  HonorHealth Research Institute (3)  ·  Institut Paoli-Calmettes (3)

Countries

United States (148)  ·  China (27)  ·  France (19)  ·  Italy (19)  ·  Canada (16)  ·  Germany (16)  ·  Denmark (14)  ·  South Korea (13)  ·  Spain (12)  ·  Netherlands (11)  ·  Sweden (11)  ·  United Kingdom (10)  ·  Australia (9)  ·  Egypt (8)  ·  Belgium (7)

Top investigators

Saleh K Saleh, MD (5)  ·  Susan E Bates, MD (3)  ·  Erkut Borazanci, MD (2)  ·  Frank Nijsen, PhD (2)  ·  Jeong Min Lee, MD (2)  ·  Lars Lundell, Professor (2)  ·  William E Gillanders, M.D. (2)  ·  Zhenfeng Zhang, MD, PhD (2)  ·  Adam Crystal, MD, PhD (1)  ·  Adrian Saftoiu, MD PhD FASGE (1)  ·  Ahmed Kamel, MD (1)  ·  Ahmed M Mahmoud, Professor (1)  ·  Aimee Lucas, MD, MS (1)

Results publications

PMID 37788341, PMID 39863139, PMID 22584629, PMID 23135763, PMID 23458160, PMID 24327518, PMID 24477709, PMID 25799130, PMID 27424289, PMID 27475674, PMID 27727233, PMID 27870743, PMID 28053024, PMID 28493288, PMID 28672195, PMID 28732391, PMID 28744123, PMID 28939558, PMID 28952881, PMID 29186019, PMID 29361435, PMID 29362244, PMID 29374667, PMID 29383130, PMID 29452805, PMID 29846250, PMID 29864089, PMID 30161292, PMID 30184767, PMID 30261853, PMID 30405781, PMID 30473706, PMID 30677524, PMID 30724356, PMID 30975030, PMID 31101621, PMID 31104307, PMID 31197699, PMID 31401903, PMID 31533931, PMID 31592509, PMID 31672606, PMID 31672839, PMID 31676359, PMID 31746632, PMID 31831767, PMID 31882719, PMID 31894292, PMID 31960953, PMID 32408361

NIH funding

P50CA196510 (4), 2019 (2), 2015 (1), 2018 (1), 2023 (1), 75N91020C00043-0-9999-1 (1), K08CA259626 (1), K12TR004416 (1), P01CA217797 (1), P30CA033572 (1), P30CA086862 (1), P50CA127297 (1), P50CA228944 (1), R01AR060209 (1), R01CA176828 (1)